<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intravascular catheter-related infection: Epidemiology, pathogenesis, and microbiology</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jesse T Jacob, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anthony Harris, MD, MPH</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis Spelman, MBBS, FRACP, FRCPA, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Keri K Hall, MD, MS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Aug 22, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Catheter-related bloodstream infections (CRBSIs) occur in association with peripheral intravascular (IV) catheters and central venous catheters (CVCs) [<a href="#rid1">1</a>]. CVCs are increasingly used in the inpatient and outpatient setting to provide long-term venous access; bloodstream infections associated with such catheters are also known as central line-associated bloodstream infections (CLABSIs). It is estimated that approximately 90 percent of CRBSIs in the United States occur with CVCs, though the role of peripheral IVs as causes of bloodstream infection (BSI) is likely underestimated [<a href="#rid1">1-3</a>].</p><p>The epidemiology, risk factors, pathogenesis, and microbiology of intravascular catheter infections will be reviewed here. The diagnosis, treatment, and prevention of CVC-associated infections are discussed separately. (See  <a class="medical medical_review" href="/d/html/3813.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/3814.html" rel="external">"Intravascular non-hemodialysis catheter-related infection: Treatment"</a> and  <a class="medical medical_review" href="/d/html/15671.html" rel="external">"Routine care and maintenance of intravenous devices"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>In 2017, there were 24,265 central line-associated bloodstream infections (CLABSIs) reported by 3576 United States acute care hospitals to the United States Centers for Disease Control and Prevention's National Healthcare Safety Network. This represents a 19 percent decline compared with 2015 [<a href="#rid4">4</a>].</p><p>CLABSIs are an important cause of morbidity and mortality worldwide, although they may be decreasing in incidence in some areas, possibly as a result of widespread prevention efforts. As an example, the incidence of CLABSI associated with central lines among patients hospitalized in intensive care units (ICUs) in the United States decreased from 3.64 to 1.65 infections per 1000 central-line days between 2001 and 2009 [<a href="#rid5">5,6</a>]. These decreases in the United States have continued through 2015 and appear to be sustained [<a href="#rid7">7,8</a>]. A similar trend of decreasing incidence has been observed in Canada [<a href="#rid9">9</a>]. In contrast, the reported pooled incidence of CLABSI across 422 ICUs in 36 countries in Latin America, Asia, Africa, and Europe from 2004 to 2009 was substantially higher, 6.8 events per 1000 central-line days [<a href="#rid10">10</a>]. Many of these sites are in resource-limited areas, and the high incidence is thought to be related to a lack of official regulations regarding catheter care.</p><p>Although ICU patients are generally exposed to more medical devices and are more severely ill than other hospitalized patients, CLABSIs remain common in hospital wards outside the ICU. As an example, an estimated 23,000 CLABSIs occurred among patients in inpatient wards in the United States in 2009 [<a href="#rid5">5</a>]. In a prospective analysis from the Surveillance and Control of Pathogens of Epidemiologic Importance (SCOPE) database, which evaluated the characteristics of 24,179 nosocomial BSIs from 49 hospitals in the United States between 1995 and 2002, the following findings were noted [<a href="#rid11">11</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>The incidence of nosocomial BSI was 60 cases per 10,000 hospital admissions. Approximately 15 percent of cases occurred in children.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Approximately 51 percent of cases occurred in the ICU.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Intravascular devices were the most common predisposing factor. A central venous catheter was in place in 72 percent, peripheral intravenous catheter in 35 percent, and an arterial catheter in 16 percent. (See <a class="local">'Catheter factors'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mean time from admission to BSI onset ranged from 12 to 26 days and depended on the isolated pathogen.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The crude mortality rate was 27 percent.</p><p></p><p>Indwelling catheters are also a frequent source of infection in many populations who required long-term venous access, including hemodialysis and oncology patients as well as those receiving total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a>. In 2008 in the United States, an estimated 37,000 CRBSIs occurred among patients receiving outpatient hemodialysis [<a href="#rid5">5</a>]. (See  <a class="medical medical_review" href="/d/html/1843.html" rel="external">"Central venous catheters for acute and chronic hemodialysis access and their management"</a> and  <a class="medical medical_review" href="/d/html/1966.html" rel="external">"Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Management and prevention"</a> and  <a class="medical medical_review" href="/d/html/8180.html" rel="external">"Central venous catheters: Overview of complications and prevention in adults", section on 'Catheter-related infection'</a>.)</p><p>BSIs associated with the widespread use of indwelling catheters have possibly contributed to the changing epidemiology of other infections. As an example, <em>Staphylococcus aureus</em> has emerged as a leading microbial cause of infective endocarditis in tertiary care centers, as illustrated by a study of a large international cohort of patients with both native and prosthetic valve endocarditis [<a href="#rid12">12</a>]. Infection with <em>S. aureus</em> versus other pathogens was independently associated with the presumed presence of an intravascular device. (See  <a class="medical medical_review" href="/d/html/2151.html" rel="external">"Native valve endocarditis: Epidemiology, risk factors, and microbiology", section on 'Microbiology'</a>.)</p><p>The distribution of pathogens associated with CRBSI is described below. (See <a class="local">'Microbiology'</a> below.)</p><p class="headingAnchor" id="H3"><span class="h1">RISK FACTORS</span></p><p class="headingAnchor" id="H4"><span class="h2">Host factors</span><span class="headingEndMark"> — </span>Host factors commonly associated with nosocomial bloodstream infections (BSIs) include the following [<a href="#rid13">13,14</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Chronic illness</p><p class="bulletIndent1"><span class="glyph">●</span>Bone marrow transplantation</p><p class="bulletIndent1"><span class="glyph">●</span>Immune deficiency, especially neutropenia</p><p class="bulletIndent1"><span class="glyph">●</span>Malnutrition</p><p class="bulletIndent1"><span class="glyph">●</span>Total <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> administration</p><p class="bulletIndent1"><span class="glyph">●</span>Previous BSI</p><p class="bulletIndent1"><span class="glyph">●</span>Extremes of age</p><p class="bulletIndent1"><span class="glyph">●</span>Loss of skin integrity, as with burns</p><p></p><p>Patients hospitalized with burns are at particularly increased risk for nosocomial BSIs as the necrotic tissue in the burn wounds increases the susceptibility to infection, thermal trauma decreases host resistance, and the body exhibits an inflammatory reaction to these processes [<a href="#rid15">15</a>].</p><p>Neutropenic patients are also at high risk for infections, including CRBSIs. Those with an absolute neutrophil count (bands plus polymorphonuclear leukocytes) below 100 cells/mm<sup>3</sup> appear to be at the greatest risk [<a href="#rid16">16</a>]. Hematologic malignancies have been associated more highly with CLABSIs than solid tumors [<a href="#rid17">17</a>].</p><p>Among pediatric intensive care unit (ICU) patients, underlying gastrointestinal and oncologic diagnoses have also been associated with increased risk for CLABSI [<a href="#rid18">18</a>].</p><p>Infection with COVID-19 has been shown in some studies to be associated with increased risk for CLABSI [<a href="#rid19">19</a>]. In the United States, of 3200 hospitals reporting to the CDC, the standardized infection ratio (SIR) for CLABSI increased by 48 percent (95% CI: 41.6-55.5) from the third quarter of 2019 to the third quarter of 2021 [<a href="#rid20">20</a>]. In contrast, in nearly 1000 German ICUs, the incidence of CLABSIs did not increase in 2020 compared to 2019 despite increased device utilization [<a href="#rid21">21</a>]. Broad disruption of the healthcare system during the COVID-19 pandemic may be a contributing factor to altered CLABSI rates, including changes of blood culture sampling as well as catheter care and maintenance protocols, increased severity of illness in hospitals, disruptions of infection prevention activities such as routine surveillance for CLABSI and catheter-days, and decreased laboratory capacity to process cultures [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H1532914"><span class="h2">Catheter factors</span><span class="headingEndMark"> — </span>All intravascular devices confer a risk of infection, although some (eg, nontunneled central venous catheters [CVCs] and pulmonary artery catheters) carry greater risk than others (eg, peripheral venous catheters) [<a href="#rid23">23</a>].</p><p>For CVCs, the site of catheter placement affects the risk of infection, with the subclavian site being associated in some studies with less risk than other sites [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/8180.html" rel="external">"Central venous catheters: Overview of complications and prevention in adults", section on 'Incidence by type of catheter'</a> and  <a class="medical medical_review" href="/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Factors influencing catheter selection'</a> and  <a class="medical medical_review" href="/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Anatomic location'</a> and  <a class="medical medical_review" href="/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Benefits/risk for specific sites'</a>.)</p><p>Other than the type and location of the catheter, the most important extrinsic risk factors associated with the development of CRBSIs include:</p><p class="bulletIndent1"><span class="glyph">●</span>Duration of catheterization (although there is no indication for routine line changing based on number of catheter days)</p><p class="bulletIndent1"><span class="glyph">●</span>Type of catheter material</p><p class="bulletIndent1"><span class="glyph">●</span>Conditions of insertion</p><p class="bulletIndent1"><span class="glyph">●</span>Catheter-site care</p><p class="bulletIndent1"><span class="glyph">●</span>Skill of the catheter inserter</p><p></p><p>The importance of these factors varies with the site and type of intravascular catheter  (<a class="graphic graphic_table graphicRef63562" href="/d/graphic/63562.html" rel="external">table 1</a>). In general, the risk of CLABSI is comparatively elevated in the following circumstances:</p><p class="bulletIndent1"><span class="glyph">●</span>Femoral or internal jugular placement compared with subclavian placement [<a href="#rid25">25-28</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Use for hyperalimentation or hemodialysis compared with other indications [<a href="#rid13">13,29</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Submaximal compared with maximal (mask, cap, sterile gloves, gown, large drape) barrier precautions during insertion [<a href="#rid30">30,31</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Nontunneled compared with tunneled insertion [<a href="#rid32">32,33</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Tunneled insertion compared with a totally implantable device [<a href="#rid34">34-36</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Bare compared with antibiotic-impregnated catheter [<a href="#rid37">37</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Multiple-lumen compared with single-lumen peripherally inserted central catheters (PICCs) [<a href="#rid38">38</a>]</p><p></p><p>Other factors that may increase the risk of infection include thrombosis of the catheter, repeated catheterization, increased manipulation of the catheter (including catheter repair), and presence of septic foci elsewhere [<a href="#rid25">25,26,39,40</a>]. The location of patient at the time of catheter insertion (eg, hospital bed or procedure room) doesn't impact risk of subsequent infection.</p><p>The incidence of BSI associated with peripheral venous catheters is low (less than 0.2 percent), but peripheral venous catheter placement among hospitalized patients is common; as such, short-term peripheral venous catheters cause a high number of health care-associated infections. It has been estimated that 1 in 3 health care-associated <em>S. aureus</em> CRBSIs are due to peripheral intravenous catheters [<a href="#rid2">2</a>]. In a meta-analysis including more than 57,000 patients in 23 studies, PICCs were associated with a lower risk of BSI than CVCs (relative risk 0.62, 95% CI 0.40-0.94); however, among studies that reported bloodstream per catheter day, PICC-related infection occurred as often as CVC infection (incidence rate ratio 0.91, 95% CI 0.46-1.79) [<a href="#rid41">41</a>].</p><p>Detailed data describing modifiable catheter risk factors and methods of reducing the risk of infection are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Benefits/risk for specific sites'</a>.)</p><p class="headingAnchor" id="H2354186"><span class="h1">SOURCES OF INFECTION</span><span class="headingEndMark"> — </span>Bloodstream infection (BSI) associated with central venous catheters (CVCs) can be attributable to four major sources: most often colonization from the skin or intraluminal or hub contamination, less often secondary seeding from a BSI, and, rarely, contamination of the infusate  (<a class="graphic graphic_figure graphicRef64065" href="/d/graphic/64065.html" rel="external">figure 1</a>) [<a href="#rid42">42</a>].</p><p class="headingAnchor" id="H2354193"><span class="h2">Skin colonization</span><span class="headingEndMark"> — </span>The most common source of CVC-related infections is colonization of the intracutaneous and intravascular portions of the catheter by microorganisms from the patient's skin and occasionally the hands of health care workers (on insertion or as a result of manipulation) [<a href="#rid43">43-45</a>]. Furthermore, a number of studies have found a strong correlation between heavy skin colonization and both catheter colonization and subsequent catheter-related infection, especially with short-term intravascular devices [<a href="#rid44">44,46-48</a>]. Microorganisms gain access to the catheter wound and migrate along the catheter-subcutaneous tract into the fibrin sheath that surrounds intravascular catheters. Scanning electron micrographs reveal that both the external and internal surfaces of catheters can become colonized with microorganisms [<a href="#rid49">49</a>].</p><p>The deposition of biofilm on the external and internal surface of vascular catheters is thought to play an important role in the colonization process. The biofilm is produced by a combination of host factors (eg, fibrinogen and fibrin) and microbial products (eg, glycocalyx or "slime").</p><p>Thus, it is not surprising that common skin commensals, such as <em>S. aureus</em> and coagulase-negative staphylococci, are often isolated from colonized catheters and patients with primary BSIs. (See <a class="local">'Microbiology'</a> below.)</p><p class="headingAnchor" id="H2354200"><span class="h2">Intraluminal contamination</span><span class="headingEndMark"> — </span>Intraluminal and/or hub contamination is an important source of BSI in patients with centrally inserted CVCs that are in place for more than two weeks or in patients with a surgically implanted device [<a href="#rid50">50-53</a>]. In one report in neonates, for example, catheter-related sepsis occurred with 26 percent of 113 catheters [<a href="#rid53">53</a>]. The infecting organism was grown from the catheter hub before or at the time of diagnosis of bacteremia in 54 percent of cases. A study from Spain found that a hub chamber containing iodinated alcohol significantly reduced both colonization and BSIs related to CVCs in intensive care unit patients [<a href="#rid54">54</a>]. (See  <a class="medical medical_review" href="/d/html/115957.html" rel="external">"Central venous access: Device and site selection in adults", section on 'Antimicrobial-impregnated catheters'</a>.)</p><p class="headingAnchor" id="H2354207"><span class="h2">Hematogenous seeding</span><span class="headingEndMark"> — </span>Hematogenous seeding of the device can occur during a BSI originating from another focus of infection, often from a gastrointestinal site; this is most likely to occur in critically ill patients or those with long-term catheters [<a href="#rid25">25,46</a>]. Recurrent bacteremia from the catheter may be difficult to distinguish from worsening of the primary focus of infection; removal of the catheter may help distinguish between these possibilities.</p><p class="headingAnchor" id="H2354214"><span class="h2">Infusate contamination</span><span class="headingEndMark"> — </span>Administration of contaminated infusate or additives, such as a contaminated heparin flush, can result in a BSI. Organisms may contaminate infusate by several mechanisms: during manufacture, during solution preparation, via retrograde contamination from a contaminated catheter, or handling by health care workers. This is now a rare source of BSI and generally causes epidemic infections [<a href="#rid55">55-59</a>]. Use of diluted <a class="drug drug_general" data-topicid="9244" href="/d/drug information/9244.html" rel="external">chlorhexidine</a> via contaminated atomizers for cutaneous disinfection has similarly been associated with at least two outbreaks of BSIs and should be avoided [<a href="#rid60">60</a>].</p><p>Particular features can suggest the diagnosis. Infusate-related infections should be suspected when sepsis occurs in an otherwise low-risk patient receiving an intravenous solution or when there is a cluster of primary BSIs with an unusual organism, often an uncommon gram-negative bacillus. The infection is confirmed by the isolation of the same organism from both the infusate and percutaneous blood culture.</p><p class="headingAnchor" id="H8"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H3230168963"><span class="h2">General principles</span><span class="headingEndMark"> — </span>Prior to the 1980s, gram-negative aerobes were the predominant organisms associated with nosocomial bloodstream infections (BSIs). Since then, gram-positive aerobes (eg, coagulase-negative staphylococci, <em>S. aureus</em>, and <em>Enterococcus</em>) and <em>Candida</em> species have increased in relative importance [<a href="#rid11">11,61</a>]. </p><p>As an example, the following distribution of pathogens was noted in the United States Centers for Disease Control and Prevention's National Healthcare Safety Network between 2011 and 2014 [<a href="#rid62">62</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Coagulase-negative staphylococci – 16.4 percent</p><p class="bulletIndent1"><span class="glyph">●</span><em>S. aureus</em> – 13.2 percent</p><p class="bulletIndent1"><span class="glyph">●</span>Enterococci – 15.2 percent</p><p class="bulletIndent1"><span class="glyph">●</span><em>Candida</em> species – 13.3 percent</p><p class="bulletIndent1"><span class="glyph">●</span><em>Klebsiella</em> species – 8.4 percent</p><p class="bulletIndent1"><span class="glyph">●</span><em>Escherichia coli</em> – 5.4 percent</p><p class="bulletIndent1"><span class="glyph">●</span><em>Enterobacter</em> species – 4.4 percent</p><p class="bulletIndent1"><span class="glyph">●</span><em>Pseudomonas</em> species – 4 percent</p><p></p><p>Subsequent surveillance reports in the United States and Europe have documented similar microbiologic distributions, with coagulase-negative staphylococci, <em>S. aureus</em>, enterococci, and candidal species accounting for the majority of CRBSIs [<a href="#rid63">63-65</a>] and a trend toward more antimicrobial resistance among the pathogens [<a href="#rid62">62</a>]. The predominance of staphylococcal species, which are common constituents of the skin microbiome, reflects the observation that central venous catheter (CVC) infections are most commonly attributable to the patient's skin microbiome [<a href="#rid66">66</a>]. Besides staphylococci, enterococci, <em>Candida</em> spp, and <em>Klebsiella</em> spp are increasingly recognized as BSI pathogens in National Healthcare Safety Network reports [<a href="#rid67">67</a>].</p><p>A report from United States Centers for Disease Control National Healthcare Safety Network from 2011 to 2017 demonstrated some changes of trends in the pathogens associated with 136,264 CLABSIs [<a href="#rid68">68</a>]. Enterobacteriaceae was the most commonly reported pathogen group in all sites except adult intensive care units, for which the most commonly reported pathogen group was <em>Candida</em> spp. This analysis highlights the important role of Enterobacteriaceae in CRBSIs.</p><p>Gram-negative bacilli may account from 16-31 percent of CLABSIs [<a href="#rid11">11,62</a>]. The most commonly isolated organisms include <em>E. coli</em>, <em>Klebsiella pneumoniae</em>, <em>Pseudomonas</em> species, <em>Enterobacter </em>species, <em>Serratia </em>species, and <em>Acinetobacter </em>species. <em>Stenotrophomonas maltophilia</em> bacteremia is a particular problem in cancer patients and is commonly CVC related [<a href="#rid69">69</a>]. A cluster of cases of catheter-related infections with gram-negative bacilli should prompt suspicion of an infusate contamination. (See <a class="local">'Infusate contamination'</a> above.)</p><p>BSIs caused by multidrug-resistant gram-negative bacilli have become a major concern because of increased rates of treatment failure and death. (See  <a class="medical medical_review" href="/d/html/3149.html" rel="external">"Gram-negative bacillary bacteremia in adults", section on 'Antibiotic resistance'</a>.)</p><p>Fungi, especially <em>Candida</em> species, account for up to 27 percent of CLABSIs [<a href="#rid11">11,67,68</a>]. Fungal infections are a particular concern in patients receiving a high concentration of glucose in intravenous hyperalimentation. <em>Candida</em> species also produce glycocalyx, which enhances their ability to colonize CVCs. Candida infections with CVCs occur more frequently in immunosuppressed patients and in patients who have received multiple antibacterial antibiotics [<a href="#rid70">70</a>]. Issues related to candidemia are discussed further separately. (See  <a class="medical medical_review" href="/d/html/2462.html" rel="external">"Clinical manifestations and diagnosis of candidemia and invasive candidiasis in adults"</a> and  <a class="medical medical_review" href="/d/html/2430.html" rel="external">"Management of candidemia and invasive candidiasis in adults"</a>.)</p><p>BSI related to CVCs occasionally may be due to more than one microorganism [<a href="#rid66">66</a>]. CVC-related infection due to anaerobic bacteria is exceedingly rare.</p><p class="headingAnchor" id="H1533861"><span class="h2">Special populations</span><span class="headingEndMark"> — </span>Certain patient populations have a different epidemiology of BSI with regard to microbial etiology:</p><p class="bulletIndent1"><span class="glyph">●</span>Among burn patients, <em>Pseudomonas aeruginosa</em> is the most frequently isolated gram-negative pathogen and, in one series, accounted for 16 percent of all cases of bloodstream infection [<a href="#rid71">71</a>]. In a prospective study of 45 bacteremic burn patients in India, <em>Pseudomonas</em> species were the most common isolates, responsible for 42 percent of cases [<a href="#rid72">72</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients with hematologic and nonhematologic malignancies, gram-negative pathogens predominate [<a href="#rid73">73</a>]. This association may be due to the translocation of gut bacteria in patients with altered mucosal barriers, and thus, the contribution of the catheter to the infection may be debatable [<a href="#rid74">74</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In hemodialysis patients, gram-positive organisms reflecting skin microbiome are responsible for most catheter-related infections. (See  <a class="medical medical_review" href="/d/html/1843.html" rel="external">"Central venous catheters for acute and chronic hemodialysis access and their management"</a> and  <a class="medical medical_review" href="/d/html/1966.html" rel="external">"Tunneled hemodialysis catheter-related bloodstream infection (CRBSI): Management and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In infections associated with needleless access devices, hydrophilic gram-negative pathogens such as <em>Pseudomonas</em> species, <em>Klebsiella</em> species, <em>Stenotrophomonas</em> (<em>Xanthomonas</em>) species, <em>Acinetobacter</em> species, and <em>Serratia marcescens</em> appear to be the most frequently isolated pathogens [<a href="#rid75">75-77</a>]. It is thought that the devices are exposed to these pathogens during patient bathing or showering.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In the ambulatory setting, children younger than three years or without recent hospitalization (within the week prior to presentation) may have an increased likelihood of polymicrobial CLABSIs [<a href="#rid78">78</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients, particularly very young infants, receiving intravenous lipids, <em>Malassezia furfur</em>, a lipophilic yeast, has been identified as a cause of BSIs [<a href="#rid79">79</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In patients receiving a high concentration of glucose in intravenous hyperalimentation, fungal infections, and <em>Candida</em> species in particular, are a particular concern.</p><p></p><p class="headingAnchor" id="H1533822"><span class="h2">Infusate contamination</span><span class="headingEndMark"> — </span>BSIs related to infusion of contaminated fluids generally involve gram-negative bacilli, including <em>Klebsiella</em>, <em>Citrobacter</em>, or non-aeruginosa <em>Pseudomonas</em> species. Enterobacteriaceae, specifically, are usually associated with contaminated glucose-containing infusates. Fungi, especially <em>Candida parapsilosis</em>, are often associated with contaminated hypertonic <a class="drug drug_general" data-topicid="10307" href="/d/drug information/10307.html" rel="external">parenteral nutrition</a> infusate [<a href="#rid42">42</a>]. A cluster of cases of BSI involving the same gram-negative or fungal organism should prompt an investigation into the possibility of contaminated infusate. (See <a class="local">'Infusate contamination'</a> above.)</p><p class="headingAnchor" id="H28543658"><span class="h2">Local infection</span><span class="headingEndMark"> — </span>Infections of the insertion or exit site, pocket, or tunnel are generally due to the same organisms listed above (see <a class="local">'Microbiology'</a> above). <em>S. aureus </em>and <em>P. aeruginosa</em> may be isolated in a greater proportion of these local infections than in CVC-related BSIs.</p><p class="headingAnchor" id="H116444886"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/17165.html" rel="external">"Patient education: Central line infections (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H425855"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span>About half of nosocomial bloodstream infections (BSIs) occur in intensive care units, and the majority are associated with the presence of an intravascular device. Catheter-related BSIs (CRBSIs) are an important cause of morbidity and mortality worldwide, including resource-limited settings. (See <a class="local">'Introduction'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Hospitalized patients with burns or neutropenia are at particularly increased risk for nosocomial BSIs. Other host risk factors include immune deficiencies in general, chronic illness, and malnutrition. (See <a class="local">'Host factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>All types of intravascular catheters pose significant but varying risk of infection. Duration of catheterization, catheter material, insertion conditions, and site care also impact the risk of catheter-associated infections  (<a class="graphic graphic_table graphicRef63562" href="/d/graphic/63562.html" rel="external">table 1</a>). (See <a class="local">'Catheter factors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>BSI associated with central venous catheters can be attributed to four major sources: colonization from the skin, intraluminal or hub contamination, secondary seeding from a BSI, and contamination of the infusate  (<a class="graphic graphic_figure graphicRef64065" href="/d/graphic/64065.html" rel="external">figure 1</a>). Infections related to the administration of contaminated intravenous fluids are rare but should be suspected when bacteremia occurs in an otherwise low-risk patient or when there is a cluster of BSIs with unusual organisms. (See <a class="local">'Sources of infection'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The skin microbiome is an important source of intravascular catheter infection. Coagulase-negative staphylococci and <em>Staphylococcus aureus</em>, common skin commensals, are common isolates from nosocomial BSIs. <em>Candida</em> spp are the most frequent pathogen for central line-associated BSIs in adult intensive care units. Gram-negative pathogens are increasing in frequency and predominate in patients with hematologic and nonhematologic malignancies. Infections with multidrug-resistant organisms are associated with high rates of treatment failure and death. (See <a class="local">'Microbiology'</a> above.)</p><p></p><p class="headingAnchor" id="H1721859204"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Jeffrey Band, MD, FACP, FIDSA, and Robert Gaynes, MD, who contributed to earlier versions of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Mayer J, Greene T, Howell J, et al. Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance. Clin Infect Dis 2012; 55:364.</a></li><li><a class="nounderline abstract_t">Mermel LA. Short-term Peripheral Venous Catheter-Related Bloodstream Infections: A Systematic Review. Clin Infect Dis 2017; 65:1757.</a></li><li><a class="nounderline abstract_t">Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132:391.</a></li><li class="breakAll">United States Centers for Disease Control and Prevention. Current HAI Progress Report. https://www.cdc.gov/hai/data/portal/progress-report.html (Accessed on March 26, 2019).</li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep 2011; 60:243.</a></li><li><a class="nounderline abstract_t">Fagan RP, Edwards JR, Park BJ, et al. Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010. Infect Control Hosp Epidemiol 2013; 34:893.</a></li><li><a class="nounderline abstract_t">Pronovost PJ, Watson SR, Goeschel CA, et al. Sustaining Reductions in Central Line-Associated Bloodstream Infections in Michigan Intensive Care Units: A 10-Year Analysis. Am J Med Qual 2016; 31:197.</a></li><li><a class="nounderline abstract_t">Dudeck MA, Edwards JR, Allen-Bridson K, et al. National Healthcare Safety Network report, data summary for 2013, Device-associated Module. Am J Infect Control 2015; 43:206.</a></li><li><a class="nounderline abstract_t">Fontela PS, Platt RW, Rocher I, et al. Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review. Am J Infect Control 2012; 40:221.</a></li><li><a class="nounderline abstract_t">Rosenthal VD, Bijie H, Maki DG, et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. Am J Infect Control 2012; 40:396.</a></li><li><a class="nounderline abstract_t">Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309.</a></li><li><a class="nounderline abstract_t">Fowler VG Jr, Miro JM, Hoen B, et al. Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA 2005; 293:3012.</a></li><li><a class="nounderline abstract_t">Tokars JI, Cookson ST, McArthur MA, et al. Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy. Ann Intern Med 1999; 131:340.</a></li><li><a class="nounderline abstract_t">Reunes S, Rombaut V, Vogelaers D, et al. Risk factors and mortality for nosocomial bloodstream infections in elderly patients. Eur J Intern Med 2011; 22:e39.</a></li><li class="breakAll">Tompkins RG, Burke JF. Infections of burn wounds. In: Hospital Infections, 3rd Ed, Bennett JV, Brachman PS (Eds), Little, Brown, Boston 1992.</li><li><a class="nounderline abstract_t">Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64:328.</a></li><li><a class="nounderline abstract_t">Mollee P, Jones M, Stackelroth J, et al. Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study. J Hosp Infect 2011; 78:26.</a></li><li><a class="nounderline abstract_t">Niedner MF, Huskins WC, Colantuoni E, et al. Epidemiology of central line-associated bloodstream infections in the pediatric intensive care unit. Infect Control Hosp Epidemiol 2011; 32:1200.</a></li><li><a class="nounderline abstract_t">Shukla BS, Warde PR, Knott E, et al. Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic. Emerg Infect Dis 2021; 27:2588.</a></li><li><a class="nounderline abstract_t">Lastinger LM, Alvarez CR, Kofman A, et al. Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic. Infect Control Hosp Epidemiol 2023; 44:997.</a></li><li><a class="nounderline abstract_t">Geffers C, Schwab F, Behnke M, Gastmeier P. No increase of device associated infections in German intensive care units during the start of the COVID-19 pandemic in 2020. Antimicrob Resist Infect Control 2022; 11:67.</a></li><li><a class="nounderline abstract_t">Zhu NJ, Rawson TM, Mookerjee S, et al. Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage. Clin Infect Dis 2022; 75:e1082.</a></li><li><a class="nounderline abstract_t">Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc 2006; 81:1159.</a></li><li><a class="nounderline abstract_t">Parienti JJ, du Cheyron D, Timsit JF, et al. Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults. Crit Care Med 2012; 40:1627.</a></li><li><a class="nounderline abstract_t">Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med 1991; 91:197S.</a></li><li><a class="nounderline abstract_t">Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol 1990; 28:2520.</a></li><li><a class="nounderline abstract_t">Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA 2001; 286:700.</a></li><li><a class="nounderline abstract_t">Ronco C. The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care 2005; 9:631.</a></li><li><a class="nounderline abstract_t">Wilcox TA. Catheter-related bloodstream infections. Semin Intervent Radiol 2009; 26:139.</a></li><li><a class="nounderline abstract_t">Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol 1994; 15:231.</a></li><li><a class="nounderline abstract_t">Maki DG. Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia. Infect Control Hosp Epidemiol 1994; 15:227.</a></li><li><a class="nounderline abstract_t">Pessa ME, Howard RJ. Complications of Hickman-Broviac catheters. Surg Gynecol Obstet 1985; 161:257.</a></li><li><a class="nounderline abstract_t">Darbyshire PJ, Weightman NC, Speller DC. Problems associated with indwelling central venous catheters. Arch Dis Child 1985; 60:129.</a></li><li><a class="nounderline abstract_t">Groeger JS, Lucas AB, Thaler HT, et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119:1168.</a></li><li><a class="nounderline abstract_t">Ross MN, Haase GM, Poole MA, et al. Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients. Surg Gynecol Obstet 1988; 167:141.</a></li><li><a class="nounderline abstract_t">Carde P, Cosset-Delaigue MF, Laplanche A, Chareau I. Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors. Eur J Cancer Clin Oncol 1989; 25:939.</a></li><li><a class="nounderline abstract_t">Veenstra DL, Saint S, Saha S, et al. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA 1999; 281:261.</a></li><li><a class="nounderline abstract_t">Lam PW, Volling C, Chan T, et al. Impact of Defaulting to Single-Lumen Peripherally Inserted Central Catheters on Patient Outcomes: An Interrupted Time Series Study. Clin Infect Dis 2018; 67:954.</a></li><li><a class="nounderline abstract_t">Barzaghi A, Dell'Orto M, Rovelli A, et al. Central venous catheter clots: incidence, clinical significance and catheter care in patients with hematologic malignancies. Pediatr Hematol Oncol 1995; 12:243.</a></li><li><a class="nounderline abstract_t">Lundgren IS, Zhou C, Malone FR, et al. Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients. Pediatr Infect Dis J 2012; 31:337.</a></li><li><a class="nounderline abstract_t">Chopra V, O'Horo JC, Rogers MA, et al. The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2013; 34:908.</a></li><li class="breakAll">Maki DG. Infections due to infusion therapy. In: Hospital Infections, 3rd Ed, Bennett JV, Brachman PS (Eds), Little, Brown, Boston 1992. p.849.</li><li><a class="nounderline abstract_t">Snydman DR, Gorbea HF, Pober BR, et al. Predictive value of surveillance skin cultures in total-parenteral-nutrition-related infection. Lancet 1982; 2:1385.</a></li><li><a class="nounderline abstract_t">Bjornson HS, Colley R, Bower RH, et al. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery 1982; 92:720.</a></li><li><a class="nounderline abstract_t">Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct Gram staining of catheter segments. N Engl J Med 1985; 312:1142.</a></li><li><a class="nounderline abstract_t">Raad II, Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis 1995; 20:593.</a></li><li><a class="nounderline abstract_t">Guidet B, Nicola I, Barakett V, et al. Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients. Infection 1994; 22:43.</a></li><li><a class="nounderline abstract_t">Armstrong CW, Mayhall CG, Miller KB, et al. Clinical predictors of infection of central venous catheters used for total parenteral nutrition. Infect Control Hosp Epidemiol 1990; 11:71.</a></li><li><a class="nounderline abstract_t">Raad I, Costerton W, Sabharwal U, et al. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis 1993; 168:400.</a></li><li><a class="nounderline abstract_t">Liñares J, Sitges-Serra A, Garau J, et al. Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments. J Clin Microbiol 1985; 21:357.</a></li><li><a class="nounderline abstract_t">Tenney JH, Moody MR, Newman KA, et al. Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer. Arch Intern Med 1986; 146:1949.</a></li><li><a class="nounderline abstract_t">Miller JJ, Venus B, Mathru M. Comparison of the sterility of long-term central venous catheterization using single lumen, triple lumen, and pulmonary artery catheters. Crit Care Med 1984; 12:634.</a></li><li><a class="nounderline abstract_t">Salzman MB, Isenberg HD, Shapiro JF, et al. A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates. J Infect Dis 1993; 167:487.</a></li><li><a class="nounderline abstract_t">León C, Alvarez-Lerma F, Ruiz-Santana S, et al. Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study. Crit Care Med 2003; 31:1318.</a></li><li><a class="nounderline abstract_t">Maki DG. Nosocomial bacteremia. An epidemiologic overview. Am J Med 1981; 70:719.</a></li><li><a class="nounderline abstract_t">Kimura AC, Calvet H, Higa JI, et al. Outbreak of Ralstonia pickettii bacteremia in a neonatal intensive care unit. Pediatr Infect Dis J 2005; 24:1099.</a></li><li><a class="nounderline abstract_t">Ostrowsky BE, Whitener C, Bredenberg HK, et al. Serratia marcescens bacteremia traced to an infused narcotic. N Engl J Med 2002; 346:1529.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Pseudomonas bloodstream infections associated with a heparin/saline flush--Missouri, New York, Texas, and Michigan, 2004-2005. MMWR Morb Mortal Wkly Rep 2005; 54:269.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Update: Delayed onset Pseudomonas fluorescens bloodstream infections after exposure to contaminated heparin flush--Michigan and South Dakota, 2005-2006. MMWR Morb Mortal Wkly Rep 2006; 55:961.</a></li><li><a class="nounderline abstract_t">Tena D, Carranza R, Barberá JR, et al. Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit. Eur J Clin Microbiol Infect Dis 2005; 24:727.</a></li><li><a class="nounderline abstract_t">Banerjee SN, Emori TG, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med 1991; 91:86S.</a></li><li><a class="nounderline abstract_t">Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 2016; 37:1288.</a></li><li><a class="nounderline abstract_t">Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996.</a></li><li class="breakAll">ECDC surveillance report: Surveillance of healthcare-associated infections in Europe, 2007. http://www.ecdc.europa.eu/en/publications/Publications/120215_SUR_HAI_2007.pdf (Accessed on November 28, 2012).</li><li><a class="nounderline abstract_t">Ong DS, Bonten MJ, Safdari K, et al. Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia. Clin Infect Dis 2015; 61:1413.</a></li><li><a class="nounderline abstract_t">Haslett TM, Isenberg HD, Hilton E, et al. Microbiology of indwelling central intravascular catheters. J Clin Microbiol 1988; 26:696.</a></li><li><a class="nounderline abstract_t">Chitnis AS, Edwards JR, Ricks PM, et al. Device-associated infection rates, device utilization, and antimicrobial resistance in long-term acute care hospitals reporting to the National Healthcare Safety Network, 2010. Infect Control Hosp Epidemiol 2012; 33:993.</a></li><li><a class="nounderline abstract_t">Novosad SA, Fike L, Dudeck MA, et al. Pathogens causing central-line-associated bloodstream infections in acute-care hospitals-United States, 2011-2017. Infect Control Hosp Epidemiol 2020; 41:313.</a></li><li><a class="nounderline abstract_t">Boktour M, Hanna H, Ansari S, et al. Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients. Cancer 2006; 106:1967.</a></li><li><a class="nounderline abstract_t">Chan S, Baley ED, Hossain J, Di Pentima MC. Candida species bloodstream infections in hospitalised children: A 10-year experience. J Paediatr Child Health 2015; 51:857.</a></li><li><a class="nounderline abstract_t">Brusselaers N, Monstrey S, Snoeij T, et al. Morbidity and mortality of bloodstream infections in patients with severe burn injury. Am J Crit Care 2010; 19:e81.</a></li><li><a class="nounderline abstract_t">Mir MA, Anjum S, Mir RA, et al. Prevalence of various bacteria and their susceptibility pattern in burn unit of governmental medical college and hospital Srinagar. The Internet Journal of Microbiology 2012; 10:5580.</a></li><li><a class="nounderline abstract_t">Nørgaard M, Larsson H, Pedersen G, et al. Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br J Haematol 2006; 132:25.</a></li><li><a class="nounderline abstract_t">Sexton DJ, Chen LF, Anderson DJ. Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes? Infect Control Hosp Epidemiol 2010; 31:1286.</a></li><li><a class="nounderline abstract_t">Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis 1999; 179:442.</a></li><li><a class="nounderline abstract_t">Toscano CM, Bell M, Zukerman C, et al. Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care. Am J Infect Control 2009; 37:327.</a></li><li><a class="nounderline abstract_t">Jarvis WR, Murphy C, Hall KK, et al. Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors. Clin Infect Dis 2009; 49:1821.</a></li><li><a class="nounderline abstract_t">Downes KJ, Metlay JP, Bell LM, et al. Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care. Clin Infect Dis 2008; 46:387.</a></li><li><a class="nounderline abstract_t">Long JG, Keyserling HL. Catheter-related infection in infants due to an unusual lipophilic yeast--Malassezia furfur. Pediatrics 1985; 76:896.</a></li></ol></div><div id="topicVersionRevision">Topic 3806 Version 33.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22539665" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Agreement in classifying bloodstream infections among multiple reviewers conducting surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29020252" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Short-term Peripheral Venous Catheter-Related Bloodstream Infections: A Systematic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10691590" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Prevention of intravascular catheter-related infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10691590" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevention of intravascular catheter-related infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21368740" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23917902" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units, 1990-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25609646" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Sustaining Reductions in Central Line-Associated Bloodstream Infections in Michigan Intensive Care Units: A 10-Year Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25575913" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : National Healthcare Safety Network report, data summary for 2013, Device-associated Module.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21824682" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Epidemiology of central line-associated bloodstream infections in Quebec intensive care units: a 6-year review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21908073" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15306996" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15972563" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Staphylococcus aureus endocarditis: a consequence of medical progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10475886" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Prospective evaluation of risk factors for bloodstream infection in patients receiving home infusion therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21925041" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Risk factors and mortality for nosocomial bloodstream infections in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21925041" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Risk factors and mortality for nosocomial bloodstream infections in elderly patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5216294" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21459476" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Catheter-associated bloodstream infection incidence and risk factors in adults with cancer: a prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22080659" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Epidemiology of central line-associated bloodstream infections in the pediatric intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34352195" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Bloodstream Infection Risk, Incidence, and Deaths for Hospitalized Patients during Coronavirus Disease Pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35591782" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Continued increases in the incidence of healthcare-associated infection (HAI) during the second year of the coronavirus disease 2019 (COVID-19) pandemic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35526018" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : No increase of device associated infections in German intensive care units during the start of the COVID-19 pandemic in 2020.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34596212" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16970212" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22511140" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1928165" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2254429" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11495620" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16356251" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21326505" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Catheter-related bloodstream infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8207189" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8207188" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Yes, Virginia, aseptic technique is very important: maximal barrier precautions during insertion reduce the risk of central venous catheter-related bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3929413" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Complications of Hickman-Broviac catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3977384" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Problems associated with indwelling central venous catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8239247" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Infectious morbidity associated with long-term use of venous access devices in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3400032" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Comparison of totally implanted reservoirs with external catheters as venous access devices in pediatric oncologic patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2666137" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9918482" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29635457" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Impact of Defaulting to Single-Lumen Peripherally Inserted Central Catheters on Patient Outcomes: An Interrupted Time Series Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7640177" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Central venous catheter clots: incidence, clinical significance and catheter care in patients with hematologic malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22146741" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Central venous catheter repair is associated with an increased risk of bacteremia and central line-associated bloodstream infection in pediatric patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23917904" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23917904" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : The risk of bloodstream infection associated with peripherally inserted central catheters compared with central venous catheters in adults: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6129473" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Predictive value of surveillance skin cultures in total-parenteral-nutrition-related infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6812229" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2580237" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Rapid diagnosis of intravascular catheter-associated infection by direct Gram staining of catheter segments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7756481" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8181841" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2107249" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Clinical predictors of infection of central venous catheters used for total parenteral nutrition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8335977" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3920239" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Pathogenesis of catheter sepsis: a prospective study with quantitative and semiquantitative cultures of catheter hub and segments.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3767541" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Adherent microorganisms on lumenal surfaces of long-term intravenous catheters. Importance of Staphylococcus epidermidis in patients with cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6430645" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Comparison of the sterility of long-term central venous catheterization using single lumen, triple lumen, and pulmonary artery catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8421188" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : A prospective study of the catheter hub as the portal of entry for microorganisms causing catheter-related sepsis in neonates.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12771597" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Antiseptic chamber-containing hub reduces central venous catheter-related infection: a prospective, randomized study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7211906" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Nosocomial bacteremia. An epidemiologic overview.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371873" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Outbreak of Ralstonia pickettii bacteremia in a neonatal intensive care unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12015392" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Serratia marcescens bacteremia traced to an infused narcotic.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15788991" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Pseudomonas bloodstream infections associated with a heparin/saline flush--Missouri, New York, Texas, and Michigan, 2004-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16960550" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Update: Delayed onset Pseudomonas fluorescens bloodstream infections after exposure to contaminated heparin flush--Michigan and South Dakota, 2005-2006.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16283217" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1928197" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27573805" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18947320" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18947320" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26179013" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Epidemiology, Management, and Risk-Adjusted Mortality of ICU-Acquired Enterococcal Bacteremia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3366864" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Microbiology of indwelling central intravascular catheters.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22961018" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Device-associated infection rates, device utilization, and antimicrobial resistance in long-term acute care hospitals reporting to the National Healthcare Safety Network, 2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31915083" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Pathogens causing central-line-associated bloodstream infections in acute-care hospitals-United States, 2011-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16565968" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25941056" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Candida species bloodstream infections in hospitalised children: A 10-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21041189" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Morbidity and mortality of bloodstream infections in patients with severe burn injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Prevalence of various bacteria and their susceptibility pattern in burn unit of governmental medical college and hospital Srinagar</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16371016" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Short-term mortality of bacteraemia in elderly patients with haematological malignancies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20979492" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Current definitions of central line-associated bloodstream infection: is the emperor wearing clothes?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9878029" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19406332" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Gram-negative bloodstream infections in hematopoietic stem cell transplant patients: the roles of needleless device use, bathing practices, and catheter care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19911973" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Health care-associated bloodstream infections associated with negative- or positive-pressure or displacement mechanical valve needleless connectors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18181737" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Polymicrobial bloodstream infections among children and adolescents with central venous catheters evaluated in ambulatory care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3934637" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Catheter-related infection in infants due to an unusual lipophilic yeast--Malassezia furfur.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
